Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 14, 2022
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
Tue, September 13, 2022
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
Emily Bodnar Maintained (VTYX) at Strong Buy with Increased Target to $50 on, Sep 13th, 2022
Emily Bodnar of HC Wainwright & Co., Maintained "Ventyx Biosciences, Inc." (VTYX) at Strong Buy with Increased Target from $36 to $50 on, Sep 13th, 2022.
Emily has made no other calls on VTYX in the last 4 months.
There are 4 other peers that have a rating on VTYX. Out of the 4 peers that are also analyzing VTYX, 0 agree with Emily's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Emily
- Jeff Jones of "Oppenheimer" Maintained at Buy with Increased Target to $65 on, Monday, September 12th, 2022
- Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $45 on, Wednesday, September 7th, 2022
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, August 17th, 2022
- Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $63 on, Tuesday, August 16th, 2022
